No Link Between Flu or Flu Vaccine and Autism, Study Finds
A new study shows that babies of pregnant women who get the flu or who are vaccinated against the flu do not have an increased risk for Autism Spectrum Disorder.
Topical Use of Fibrin Sealant Can Reduce Blood Loss and Need for Transfusion in Total Knee and Hip Arthroplasty
To assess the safety and effectiveness of topical administration of fibrin sealants on postoperative blood loss and blood requirements in patients undergoing total hip arthroplasty (THA) and total knee arthroplasty (TKA), Chinese investigators searched electronic medical databases through February 2016 to identify randomized clinical trials (RCTs) for inclusion in a meta-analysis.
Infusion of BPX-501 T Cells Renders Haplo-HSCT a First-Line Option for Children with PI
A Phase I/II study indicates that haplo identical hematopoietic stem cell transplantation (haplo-HSCT), after depletion of α/β T cells and B cells followed by adoptive infusion of donorBPX-501 cells, is an effective alternative for children with primary immunodeficiency disease (PI) in need of an urgent allograft or lacking a suitable human leukocyte antigen (HLA)-matched donor.
Study Identifies Why TB Vaccines Are Ineffective
Researchers at the Washington University School of Medicine in St. Louis have discovered the reason the BCG vaccine and investigational vaccine candidates are not more effective.
New Autoimmune Disease Treatments Could Cause Fewer Side Effects
Because many of the current treatments for autoimmune diseases leave patients at greater risk of developing other opportunistic illnesses, a research team at the University of Oxford in England has been using genetics to possibly minimize the side effects of treatment.
Similar Efficacy with Use of Subcutaneous and Intravenous Immunoglobulin in CIDP and MMN: Meta-Analysis
Canadian investigators conducted a meta-analysis of published reports evaluating the efficacy and safety of subcutaneous and intravenous immunoglobulin therapy for two chronic autoimmune
neuropathies.
Human Alpha-1 Antitrypsin Improves Early Posttransplant Lung Function in Pig Lung Transplant Model
Investigators at Toronto General Research Institute used a pig lung transplant model to determine whether human A1AT could attenuate reperfusion injury after prolonged hypothermic preservation.
FDA Approves First Human Trial of a Zika Vaccine
The U.S. Food and Drug Administration has approved the first human trial of an experimental Zika virus vaccine.
Study Finds Influenza Vaccine’s Effectiveness Can Be Improved
Research conducted at the University of Texas at Austin found that how the influenza (flu) vaccine produces antibodies to protect against disease could be used to improve the vaccine.
Phase II Trial Launched of AAT for the Prevention of Lung Transplant Rejection
Kamada has initiated a Phase II clinicaltrial with its proprietary Alpha-1Antitrypsin (AAT) for the prevention oflung transplant rejection.
